Humacyte, Inc. (HUMA)
0.4112
-0.06
(-12.47%)
USD |
NASDAQ |
Oct 30, 16:00
0.42
+0.01
(+2.14%)
After-Hours: 20:00
Humacyte Total Return Level : 0.4112 for Oct. 30, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 30, 2026 | 0.4112 |
| October 29, 2026 | 0.4698 |
| October 28, 2026 | 0.4701 |
| October 27, 2026 | 0.4463 |
| October 26, 2026 | 0.4006 |
| October 23, 2026 | 0.4354 |
| October 22, 2026 | 0.4131 |
| October 21, 2026 | 0.4112 |
| October 20, 2026 | 0.406 |
| October 19, 2026 | 0.4011 |
| October 16, 2026 | 0.429 |
| October 15, 2026 | 0.4395 |
| October 14, 2026 | 0.3541 |
| October 13, 2026 | 0.3589 |
| October 12, 2026 | 0.3896 |
| October 09, 2026 | 0.4053 |
| October 08, 2026 | 0.4471 |
| October 07, 2026 | 0.4723 |
| October 06, 2026 | 0.478 |
| October 05, 2026 | 0.50 |
| October 02, 2026 | 0.5215 |
| October 01, 2026 | 0.5029 |
| September 30, 2026 | 0.5177 |
| September 29, 2026 | 0.5327 |
| September 28, 2026 | 0.5472 |
| Date | Value |
|---|---|
| September 25, 2026 | 0.5573 |
| September 24, 2026 | 0.5687 |
| September 23, 2026 | 0.5657 |
| September 22, 2026 | 0.5828 |
| September 21, 2026 | 0.59 |
| September 18, 2026 | 0.5856 |
| September 17, 2026 | 0.5751 |
| September 16, 2026 | 0.57 |
| September 15, 2026 | 0.5516 |
| September 14, 2026 | 0.561 |
| September 11, 2026 | 0.5676 |
| September 10, 2026 | 0.5671 |
| September 09, 2026 | 0.579 |
| September 08, 2026 | 0.5949 |
| September 04, 2026 | 0.6049 |
| September 03, 2026 | 0.596 |
| September 02, 2026 | 0.5966 |
| September 01, 2026 | 0.5704 |
| August 31, 2026 | 0.6014 |
| August 28, 2026 | 0.6501 |
| August 27, 2026 | 0.6927 |
| August 26, 2026 | 0.6816 |
| August 25, 2026 | 0.7012 |
| August 24, 2026 | 0.6622 |
| August 21, 2026 | 0.6422 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Amgen, Inc. | 697.82 |
| Altimmune, Inc. | 7.918 |
| Protalix Biotherapeutics, Inc. | 2.59 |
| Taysha Gene Therapies, Inc. | 4.13 |
| Agenus, Inc. | 6.84 |